<DOC>
	<DOCNO>NCT02095379</DOCNO>
	<brief_summary>In study , investigator aim investigate prevalence clinical course oligosecretary myeloma .</brief_summary>
	<brief_title>Oligosecretary Myeloma : Prevalence Its Clinical Significance</brief_title>
	<detailed_description>Oligosecretary myeloma subgroup multiple myeloma ( MM ) characterize low level serum urine monoclonal ( M ) protein thresholds measurable disease ( serum M protein ≥ 1g/dL , urine M protein ≥ 200mg/day ) . Patients oligosecretary myeloma establish method disease monitor clinical information regard oligosecretary myeloma still largely unknown . In study , aim investigate prevalence clinical course oligosecretary myeloma .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<criteria>subgroup multiple myeloma ( MM ) characterize low level serum urine monoclonal ( M ) protein thresholds measurable disease ( serum M protein ≥ 1g/dL , urine M protein ≥ 200mg/day ) available clinical data patient without available clinical data</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>oligosecretary multiple myeloma</keyword>
</DOC>